Active Funding Opportunity Announcements (FOAs) for All NICHD
NICHD issues and participates in various FOAs to support research activities and training.
Investigator-Initiated (Unsolicited) Projects
To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.
Active FOAs for NICHD
Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.
| Announcement Number | Submissions Date(s) | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|
| RFA-NS-19-043 | New February 10, 2020, June 10, 2020, October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022 Resubmission March 10, 2020, July 10, 2020, November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
November 12, 2022 | K99/R00 | BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) |
| RFA-NS-19-044 | New February 10, 2020; June 10, 2020; October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022 Resubmission March 10, 2020; July 10, 2020; November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
November 12, 2022 | K99/R00 | BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) |
| RFA-MH-20-325 | January 9, 2020 All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement. |
December 24, 2019 | U19 | Limited Competition: Consortium on Biomarker and Outcome Measures of Social Impairment for Use in Clinical Trials in Autism Spectrum Disorder (U19 Clinical Trial Not Allowed) |
| PAR-20-036 | Only accepting applications for the AIDS Application Due Dates listed below. | September 8, 2022 | R01 | Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional) |
| PAR-20-042 | March 30, 2020, March 30, 2021, March 30, 2022 | April 1, 2022 | R03 | NCMRR Early Career Research Award (R03 Clinical Trial Optional) |
| PAR-20-031 | December 20, 2019; November 30, 2020; November 30, 2021 | December 21, 2021 | R01 | Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) |
| PAR-20-032 | December 20, 2019; November 30, 2020; November 30, 2021 | December 21, 2021 | R03 | Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional) |
| PAR-20-033 | December 20, 2019; November 30, 2020; November 30, 2021 | December 21, 2021 | R21 | Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional) |
| RFA-HD-20-002 | Only accepting applications for the AIDS Application Due Date(s) listed below. | December 6, 2019 | P01 | Pediatric HIV/AIDS Cohort Study (PHACS) 2020 (P01 Clinical Trial Not Allowed) |
| RFA-NS-20-009 | January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 | September 9, 2022 | R41/R42 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
| RFA-NS-20-010 | January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 | September 9, 2022 | R43/R44 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) |
| RFA-NS-20-011 | January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 | September 9, 2022 | R43/R44 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) |
| RFA-NS-20-008 | January 8, 2020, April 7, 2020, September 9, 2020, January 6, 2021, April 6, 2021, September 8, 2021, January 6, 2022, April 6, 2022, and September 8, 2022 | September 9, 2022 | R41/R42 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) |
| RFA-HD-20-013 | November 29, 2019 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
November 30, 2019 | K12 | Womens Reproductive Health Research (WRHR) Career Development Program (K12 Clinical Trial Optional) |
| RFA-MD-20-001 | November 22, 2019 All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
November 23, 2019 | P50 | Limited Competition: Specialized Centers of Excellence on Environmental Health Disparities Research (P50) |
| RFA-NS-20-003 | December 16, 2019. No late applications will be accepted for this Funding Opportunity Announcement. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. |
December 17, 2019 | R25 | NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed) |
| PAR-19-373 | March 17, 2020; March 17, 2021, | March 18, 2021 | R01 | Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) |
| PAR-19-384 | March 17, 2020; March 17, 2021 | March 18, 2021 | R01 | Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) |
| RFA-HD-20-019 | December 10, 2019, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement |
December 11, 2019 | R43/R44 | Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional) |
| RFA-HD-20-008 | December 2, 2019 | December 3, 2019 | R61/R33 | Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exposed Uninfected (HEU) Populations (R61/R33 Clinical Trial Not Allowed) |
BACK TO TOP